Revolutionizing medical diagnostics, from cell culture to immunoassays to molecular diagnostics, built for a pandemic, Quidel continues to expand on Point-of-Care (POC) testing solutions to address the needs of physicians and laboratorians globally.
Quidel can help learning institutions develop affordable COVID-19 screening solutions from our catalog of rapid testing products.
From on-site testing to same day results and reporting, Quidel can customize an end-to-end testing solution to meet your corporation’s needs.
With “normal” activities limited, more families will take to the outdoors, the only thing, ticks don’t play by our rules, so Lyme disease could end up on the rise.
An influx of COVID-19 related hospitalizations brings patients presenting a spectra of symptoms, requiring a spectra of treatments – this convergence could lead to an increased risk of C.difficile.
From cell culture to immunoassays to molecular diagnostics, Quidel continues to expand on Point-of-Care (POC) testing solutions to address the needs of physicians and laboratorians globally.